Teva

Teva 'disappointed' by Irish consultants' boycott of its pharmaceuticals, company tells 'Post'

Teva told the Post it remains committed to working constructively with healthcare professionals across Ireland and to supporting patients through the "consistent supply of high-quality medicines."

The logistics center of Teva Pharmaceutical Industries in Shoham
In January, Israel’s Ministry of Defense signed a multi-year contract with Semiconductor Devices valued at approximately $115 million (NIS 380 million).

The curse of being Israel's most valuable company

The logistics center of Teva Pharmaceutical Industries in Shoham

Mega deal: Teva acquires Emalex for approximately $900 million

Noam Zilbershtain, senior vice president and general manager, HP Indigo; Adi Soffer Teeni, CEO of Meta Israel, vice president and member of the EMEA leadership team; and Karin Mayer Rubinstein, CEO and president of IATI.

IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience


Teva hopes generic EpiPen will sell well in U.S. market

An EpiPen, or epinephrine auto-injector, is a medication used to treat serious allergic reactions in emergencies.

EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016.

U.S. settles with Teva over keeping generic drugs off market

The agency has said that the deals cost consumers billions annually in higher drug costs.

A TEVA Pharmaceutical Industries building is seen in Jerusalem last year. (Ammar Awad/Reuters)

Teva CEO: Tough year ahead, but we're hitting cost-cutting targets

The successful Israeli-based generic medication manufacturer has been forced to downsize, but emphasized there will be no second round of restructuring or new site closures.

The CEO of Teva Pharmaceutical Industries Kare Schultz speaks during a news conference to discuss the company's 2019 outlooks in Tel Aviv, Israel February 19, 2019

Israeli scientists abroad: We want to come home

At a workshop in Tel Aviv, the country’s brightest face a hard choice. Can they bring home the skills they have acquired?

ISRAELI SCIENTISTS who reside overseas visit the Teva factory as part of a new project to encourage their return to Israel.

Israeli drug giant Teva to move offices to Tel Aviv

"The expected move-in date will be mid-2020," Teva SVP global human resources Mark Sabag told Globes.

THE TEVA building in Jerusalem.

Israeli drug-maker Teva to recall certain blood pressure medicine in U.S.

Teva has not received any reports of adverse events signaling a potential link or exposure to valsartan, the health regulator said.

Some 1,780 Jerusalemites are employed at the city’s two branches of Teva

Teva continues to wobble as rival drug receives FDA approval

Only two weeks ago, Teva received approval for its newly-developed migraine drug known as Ajovy, raising hopes of improved financial fortunes.

THE TEVA building in Jerusalem.

U.S. approval of Teva drug could help reverse company’s migraines

The newly-approved preventive migraine drug could bring in as much as $500 million in sales annually.

THE TEVA building in Jerusalem.

Will migraine drug approval make Teva a success again?

The U.S. Food and Drug Administration approved a new migraine treatment Teva created, which has potentially 39 million Americans buyers.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Teva jumps on FDA approval for generic EpiPen

THE TEVA building in Jerusalem.